JP2022518944A5 - - Google Patents
Info
- Publication number
- JP2022518944A5 JP2022518944A5 JP2021544351A JP2021544351A JP2022518944A5 JP 2022518944 A5 JP2022518944 A5 JP 2022518944A5 JP 2021544351 A JP2021544351 A JP 2021544351A JP 2021544351 A JP2021544351 A JP 2021544351A JP 2022518944 A5 JP2022518944 A5 JP 2022518944A5
- Authority
- JP
- Japan
- Prior art keywords
- diazaspiro
- trifluoroethoxy
- decane
- pyrimidine
- biphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962798827P | 2019-01-30 | 2019-01-30 | |
| US62/798,827 | 2019-01-30 | ||
| PCT/IB2020/000074 WO2020157577A1 (en) | 2019-01-30 | 2020-01-30 | A dosage regime and method for treating pulmonary arterial hypertension with rodatristat ethyl |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022518944A JP2022518944A (ja) | 2022-03-17 |
| JP2022518944A5 true JP2022518944A5 (cg-RX-API-DMAC7.html) | 2022-12-19 |
Family
ID=70285725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544351A Pending JP2022518944A (ja) | 2019-01-30 | 2020-01-30 | 肺動脈性肺高血圧症を治療するための投与レジメンおよび方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11607413B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3917531A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022518944A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210133953A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113557022A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020213746A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3128327A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021009055A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020157577A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210102887A (ko) * | 2018-11-14 | 2021-08-20 | 알타반트 사이언시스 게엠베하 | 말초 세로토닌과 관련된 질병 또는 장애를 치료하기 위한 트립토판 하이드록실라제 1 (tph1)의 결정질 스피로사이클릭 화합물 억제제 |
| AU2019382168A1 (en) | 2018-11-16 | 2021-06-03 | Altavant Sciences Gmbh | A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension |
| WO2020128614A1 (en) * | 2018-12-17 | 2020-06-25 | Altavant Sciences Gmbh | Method for treating interstital lung disease |
| CN113557022A (zh) | 2019-01-30 | 2021-10-26 | 阿尔塔万特科学公司 | 用罗达司他乙酯治疗肺动脉高压的给药方案和方法 |
| CN113784717A (zh) * | 2019-03-15 | 2021-12-10 | 阿尔塔万特科学公司 | 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药 |
| WO2023062595A1 (en) | 2021-10-14 | 2023-04-20 | Altavant Sciences Gmbh | Treatment of subjects having pulmonary arterial hypertension with rodatristat ethyl |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101815534A (zh) | 2007-07-11 | 2010-08-25 | 莱西肯医药有限公司 | 用于治疗肺动脉高压以及相关疾病和病症的方法和组合物 |
| UA119247C2 (uk) | 2013-09-06 | 2019-05-27 | РОЙВЕНТ САЙЕНСИЗ ҐмбГ | Спіроциклічні сполуки як інгібітори триптофангідроксилази |
| KR20210102887A (ko) | 2018-11-14 | 2021-08-20 | 알타반트 사이언시스 게엠베하 | 말초 세로토닌과 관련된 질병 또는 장애를 치료하기 위한 트립토판 하이드록실라제 1 (tph1)의 결정질 스피로사이클릭 화합물 억제제 |
| AU2019382168A1 (en) | 2018-11-16 | 2021-06-03 | Altavant Sciences Gmbh | A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension |
| US20200188398A1 (en) | 2018-12-17 | 2020-06-18 | Altavant Sciences Gmbh | Method for treating sarcoidosis-associated pulmonary hypertension |
| WO2020128614A1 (en) | 2018-12-17 | 2020-06-25 | Altavant Sciences Gmbh | Method for treating interstital lung disease |
| CN113557022A (zh) | 2019-01-30 | 2021-10-26 | 阿尔塔万特科学公司 | 用罗达司他乙酯治疗肺动脉高压的给药方案和方法 |
| CN113784717A (zh) * | 2019-03-15 | 2021-12-10 | 阿尔塔万特科学公司 | 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药 |
-
2020
- 2020-01-30 CN CN202080016400.5A patent/CN113557022A/zh active Pending
- 2020-01-30 KR KR1020217024232A patent/KR20210133953A/ko not_active Abandoned
- 2020-01-30 JP JP2021544351A patent/JP2022518944A/ja active Pending
- 2020-01-30 MX MX2021009055A patent/MX2021009055A/es unknown
- 2020-01-30 EP EP20718760.0A patent/EP3917531A1/en not_active Withdrawn
- 2020-01-30 US US16/777,458 patent/US11607413B2/en active Active
- 2020-01-30 CA CA3128327A patent/CA3128327A1/en active Pending
- 2020-01-30 WO PCT/IB2020/000074 patent/WO2020157577A1/en not_active Ceased
- 2020-01-30 AU AU2020213746A patent/AU2020213746A1/en not_active Abandoned
-
2023
- 2023-01-25 US US18/159,494 patent/US20240041877A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6335021B1 (en) | Composition for controlling mood disorders in healthy individuals | |
| CN106999467A (zh) | 治疗认知减退的方法 | |
| US11045447B2 (en) | Methods for inducing synaptogenesis with synaptic growth factor activating compounds | |
| CN107519159A (zh) | 复方组合物 | |
| US20160030383A1 (en) | Low-dose doxepin for treatment of sleep disorders in elderly patients | |
| KR101951220B1 (ko) | 조합 als 치료법 | |
| RU2010109359A (ru) | Азитромицин для лечения кожных заболеваний | |
| JP2024019691A (ja) | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 | |
| HRP20192189T1 (hr) | Doziranja i terapijske primjene l-4-klorokinurenina | |
| JP2010065060A (ja) | 心不全処置のための複合治療 | |
| JP2016505050A5 (cg-RX-API-DMAC7.html) | ||
| WO2020128608A1 (en) | Compound for use in a method for treating sarcoidosis-associated pulmonary hypertension | |
| JP2025511402A5 (cg-RX-API-DMAC7.html) | ||
| JP2025511401A5 (cg-RX-API-DMAC7.html) | ||
| CN109172550B (zh) | 一种复合麻醉药物 | |
| AU2013362755B2 (en) | Uses and methods for the treatment of liver diseases or conditions | |
| JP2022019937A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び/又は敗血症の予防若しくは治療のための組成物 | |
| CN113827590A (zh) | 右美托咪定在助眠药物制备中的应用 | |
| TW201244732A (en) | Ezatiostat for treating multiple myeloma | |
| EP4029503B1 (en) | Drug combinations of entecavir and a tlr7 agonist for use in the treatment of hbv | |
| AU2013301125B2 (en) | A3 adenosine receptor ligands for use in treatment of a sexual dysfunction | |
| US20190381034A1 (en) | Pharmaceutical composition and method for acute on chronic liver failure and related liver diseases | |
| RU2404976C1 (ru) | Средство, снижающее влечение к алкоголизму, фармацевтическая композиция, способ ее получения, лекарственное средство и способ лечения | |
| TW536400B (en) | Pharmaceutical composition for the treatment of immunodeficiency disease which cause by HIV infection | |
| JP2004026810A (ja) | 鼻炎用組成物 |